AAPG
Ascentage Pharma Group International
NASDAQ: AAPG · HEALTHCARE · BIOTECHNOLOGY
$22.88
+1.76% today
Updated 2026-04-30
Market cap
$2.15B
P/E ratio
—
P/S ratio
3.74x
EPS (TTM)
$-2.04
Dividend yield
—
52W range
$19 – $48
Volume
0.0M
Ascentage Pharma Group International (AAPG) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-216.50%
Operating margin
-193.30%
ROE
-154.60%
ROA
-23.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $7.67M | $-107.84M | 96.60% | -1,495.00% | -1,406.53% |
| 2017 | $6.33M | $-118.51M | 100.00% | -2,064.92% | -1,872.85% |
| 2018 | $6.81M | $-345.31M | 100.00% | -738.14% | -5,072.82% |
| 2019 | $14.51M | $-1.48B | 85.56% | -4,014.92% | -10,202.67% |
| 2020 | $12.45M | $-677.61M | 84.21% | -5,332.86% | -5,442.62% |
| 2021 | $27.91M | $-782.42M | 88.08% | -3,116.57% | -2,803.38% |
| 2022 | $209.71M | $-882.92M | 89.51% | -405.23% | -421.02% |
| 2023 | $221.98M | $-925.64M | 86.24% | -393.11% | -416.98% |
| 2024 | $980.65M | $-405.43M | 97.03% | -37.70% | -41.34% |
| 2025 | $558.48M | $-1.21B | 76.41% | -211.14% | -216.47% |